73 related articles for article (PubMed ID: 11587128)
1. Measurement of asialylated LDL in the blood of patients with coronary artery disease by antibody-lectin sandwich assay.
Mcdowell A; Young IS; Wisdom GB
Ann Clin Biochem; 2001 Sep; 38(Pt 5):499-508. PubMed ID: 11587128
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
McDowell A; Young IS; Wisdom GB
J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
[TBL] [Abstract][Full Text] [Related]
3. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
[TBL] [Abstract][Full Text] [Related]
4. Modified (desialylated) low-density lipoprotein measured in serum by lectin-sorbent assay.
Tertov VV; Sobenin IA; Orekhov AN
Clin Chem; 1995 Jul; 41(7):1018-21. PubMed ID: 7600681
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
[TBL] [Abstract][Full Text] [Related]
6. Early coronary artery disease--Usual and unusual suspects.
Markousis-Mavrogenis G; Mavrogeni S; Kolovou G
Int J Cardiol; 2016 Jan; 202():511. PubMed ID: 26447655
[No Abstract] [Full Text] [Related]
7. LDL molecular size as risk factor in coronary artery disease.
Kozma L; Fodor J; Chockalingam A; Sussex B
Acta Med Hung; 1992-1993; 49(1-2):65-77. PubMed ID: 1296188
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
[TBL] [Abstract][Full Text] [Related]
10. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
Kim HK; Chang SA; Choi EK; Kim YJ; Kim HS; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
Int J Cardiol; 2005 Jun; 101(3):435-40. PubMed ID: 15907412
[TBL] [Abstract][Full Text] [Related]
11. Apolipoproteins: correlation with carotid intimamedia thickness and coronary artery disease.
Jadhav UM; Kadam NN
J Assoc Physicians India; 2004 May; 52():370-5. PubMed ID: 15656025
[TBL] [Abstract][Full Text] [Related]
12. Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers.
Johnston N; Jernberg T; Lagerqvist B; Siegbahn A; Wallentin L
Am J Cardiol; 2006 Mar; 97(5):640-5. PubMed ID: 16490429
[TBL] [Abstract][Full Text] [Related]
13. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
Rasouli M; Kiasari AM; Mokhberi V
Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071
[TBL] [Abstract][Full Text] [Related]
14. Antibody titer against malondialdehyde-modified LDL compares with HDL cholesterol concentration in identifying angiographically verified coronary artery disease. Comparison of tests by ROC analysis.
Rontu R; Metso S; Jaakkola O; Nikkilä M; Jokela H; Lehtimäki T
Clin Chem Lab Med; 2005; 43(4):357-60. PubMed ID: 15899649
[TBL] [Abstract][Full Text] [Related]
15. The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.
Khadem-Ansari MH; Rasmi Y; Rahimi-Pour A; Jafarzadeh M
Singapore Med J; 2009 Jun; 50(6):610-3. PubMed ID: 19551315
[TBL] [Abstract][Full Text] [Related]
16. Comparison of laboratory parameters as risk factors for the presence and the extent of coronary or carotid atherosclerosis: the significance of apolipoprotein B to apolipoprotein all ratio.
Cerne D; Ledinski G; Kager G; Greilberger J; Wang X; Jürgens G
Clin Chem Lab Med; 2000 Jun; 38(6):529-38. PubMed ID: 10987202
[TBL] [Abstract][Full Text] [Related]
17. Apolipoproteins as markers and managers of coronary risk.
Chan DC; Watts GF
QJM; 2006 May; 99(5):277-87. PubMed ID: 16504986
[TBL] [Abstract][Full Text] [Related]
18. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
19. Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.
Hummel J; Westphal S; Weber-Hamann B; Gilles M; Lederbogen F; Angermeier T; Luley C; Deuschle M; Kopf D
J Clin Psychiatry; 2011 Jul; 72(7):885-91. PubMed ID: 21294998
[TBL] [Abstract][Full Text] [Related]
20. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]